Knowing that makes this upcoming trial even more likely to succeed, because they simply won't enroll anyone who's had CLBP for more than 5-6 years.
That's right @stockrock .... they will do exactly the same thing with the "Eligibility Criteria" for the additional COVID-19 ARDS trial for under 65's as well now that they have so much data, biomarkers etc etc
..... and sadly I continue to see why SI is pushing forward with the COVID-19 ARDS trial - you don't have to look far to see why more treatments are needed (last 2 days in the USA).... I just hope the NIH are wanting to pay for it again this time around ?
https://www.worldometers.info/coronavirus/
Knowing that makes this upcoming trial even more likely to...
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |